Indegene, a digital-first life sciences commercialization company, has expanded its presence in India with the opening of a new center in Pune.
By leveraging the city's highly skilled technology, management, and medical talent base, the company is enhancing its ability to help clients accelerate innovation, scale global operations, and deliver improved healthcare outcomes for patients worldwide.
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products. Its client base includes the world's top 20 biopharma companies, many emerging biotech firms, and medical device companies. Indegene has about 5,000 employees worldwide, 9 operations hubs and 20 offices across North America, Europe, and Asia.
Shares of Indegene Limited was last trading in BSE at Rs. 561.85 as compared to the previous close of Rs. 542.95. The total number of shares traded during the day was 15421 in over 677 trades.
The stock hit an intraday high of Rs. 564.45 and intraday low of 545.20. The net turnover during the day was Rs. 8596653.00.